References
1. Nardis C., Mosca L., Mastromarino P. Vaginal microbiota and viral sexually transmitted diseases. Ann Ig. 2013; 25 (5): 443-56.
2. Liu M.B., Xu S.R., He Y., et al. Diverse vaginal microbiomes in reproductive-age women with vulvovaginal candidiasis. PLoS One. 2013; 8 (11): 79-81.
3. Jahic M., Mulavdic M., Nurkic J., et al. Clinical characteristics of aerobic vaginitis and its association to vaginal candidiasis, trichomonas vaginitis and bacterial vaginosis. Med Arch. 2013; 67 (6): 428-30.
4. Sobel J.D., et al. Mixed vaginitis - more than coinfection and with therapeutic implications. Curr Infect Dis Rep. 2013; 15: 104-8.
5. Swidsinski A., Verstraelen H., Loening-Baucke V. Presence of a polymicrobial endometrial biofilm in patients with bacterial vaginosis. PLoS One. 2013; 8: 53-9.
6. Robertson S.R., McLean R.J.C. Beneficial biofilms. AIMS Bioeng. 2015; 2 (4): 437-48.
7. Cremer J., Melbinger A., Frey E. Growth dynamics and the evolution of cooperation in microbial populations. Sci Rep. 2012; 2: 281-3.
8. Petrova M.I., Lievens E., Malik S., et al. Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Front Physiol. 2015; 6: 81-4.
9. Van de Wijgert J.H., Borgdorff H., Verhelst R. The vaginal microbiota: what have we learned after a decade of molecular characterization? PLoS One. 2014; 9 (8): 105-9.
10. Rakhmatulina M.R., Nechayeva I.A. Biofilms of microorganisms and their role for the formation of resistance to anti-bacterial drugs. Vestnik dermatologii i venerologii [Journal of Dermatology and Venereology]. 2015; 60 (2): 58-62. (in Russian)
11. Macklaim J.M., Fernandes A.D., Di Bella J.M., Hammond J.A., et al. Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome. 2013; 1 (1): 12-4.
12. Sobel J.D., Reichman O., Misra D., Yoo W. Prognosis and treatment of desquamative inflammatory vaginitis. Obstet Gynecol. 2011; 117: 850-5.
13. Bibbo M., Wilbur D. Comprehensive cytopathology. London: Elsevier Health Sciences, 2014; 6: 88-9.
14. Radzinsky V.E., Ordiyants I.M. Two-stage therapy for vaginal infections. StatusPraesens. 2012; (5): 16. (in Russian)
15. Radzinsky V.E., Ordiyants I.M. The study of BIOS: a comparative evaluation of various treatment regimens for bacterial vaginosis and nonspecific vulvovaginitis. StatusPraesens. 2013; 1 (12): 52-5. (in Russian)
16. Sexually Transmitted Diseases Treatment Guidelines, 2015: Recommendations and Reports. CDC, 2015: 138 р.
17. Bebneva T.N., Dobretsova T.A. Mixed vaginal infections: a new ideology. Nonspecific vaginal infections in the practice of an obstetrician-gynecologist. Newsletter. In: V.E. Radzinsky, A.M. Savicheva (eds). Moscow, 2016: 24 р. (in Russian)
18. Swidsinski A., Loening-Baucke V., Mendling W., Dorffel Y., et al. Infection through structured polymicrobial Gardnerella biofilms (StPM-GB). Histol Histopathol. 2014; 29 (5): 567-87.
19. Breshears L.M., Edwards V.L., Ravel J., Peterson M.L. Lactobacillus crispatus inhibits growth of Gardnerella vaginalis and Neisseria gonorrhoeae on a porcine vaginal mucosa model. BMC Microbiol. 2015; 15 (1): 276.
20. Fofanova I.Yu., Prilepskaya V.N. Rational approaches to the treatment of bacterial vaginosis. Ginekologiya [Gynecology]. 2013; 15 (5): 2831. (in Russian)
21. Savicheva A.M., Rybina E.V., Ipastova I.D. bacterial vaginosis and mixed vaginal infections: is it possible to have one without the other? StatusPraesens. 2014; (23): 39-46. (in Russian)